Obiettivo Peripheral Arterial Disease (PAD) is caused by the deposition of fatty material on the inner walls of peripheral arteries causing reducing perfusion and local nutrition to the muscles and skin. The condition affect 202 million people globally and is increasing at a rate of 20% per annum due to an aging population and epidemic growth of diabetes. The social costs amounts to $210 - 380 billion per annum. Behavioural changes such as smoking cessation, healthy nutrition and exercise is recommended to reduce impact and risk. When the condition worsens, patients ability to walk and exercise is reduced. When disease progress to critical limb ischemia (unbearable pain and chronic wounds), the patients follow a trajectory towards costly vascular surgery or amputation.FlowOx targets the gap in care with a patented, cost effective and clinically promising home treatment solution. In order to secure the successful introduction of FlowOx into the market by 2020, resources are required to fill the following gaps in innovation:1) strong clinical evidence of efficacy 2) health economic assessment 3) design for large scale manufacturing and 4) a validated commercial model Germany, UK and Scandinavia. These 4 challenges will be addressed in the FlowOx project over a 30-month period. The Fast Track to Innovation Pilot program was selected to support a resource demanding and technically challenging stage of the product roadmap. The support enables Otivio to join forces with a medical device manufacturer, Innokas Medical, Finland, and UK based Univ. of Salford and Univ. of Bangor with extensive experience in clinical and health economic studies. The FlowOx project enables Otivio and Innokas to enter the world-wide PAD market, gaining a strong market positon with a home care device for PAD treatment and expected sales of over €220 million within 5 years of launch. Campo scientifico medical and health sciencesclinical medicinesurgerymedical and health sciencesclinical medicineendocrinologydiabetesmedical and health scienceshealth sciencesnutritionmedical and health sciencesclinical medicineperipheral vascular diseasesocial scienceseconomics and businessbusiness and managementcommerce Programma(i) H2020-EC - Horizon 2020 Framework Programme Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2. - PRIORITY 'Industrial leadership' Argomento(i) FTIPilot-01-2016 - Fast Track to Innovation Pilot Invito a presentare proposte H2020-FTIPilot-2016 Vedi altri progetti per questo bando Bando secondario H2020-FTIPilot-2016-1 Meccanismo di finanziamento IA - Innovation action Coordinatore OTIVIO AS Contribution nette de l'UE € 876 000,00 Indirizzo GAUSTADALLEEN 21 0349 OSLO Norvegia Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Norge Oslo og Viken Oslo Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 1 251 428,58 Partecipanti (3) Classifica in ordine alfabetico Classifica per Contributo netto dell'UE Espandi tutto Riduci tutto INNOKAS MEDICAL OY Finlandia Contribution nette de l'UE € 680 750,00 Indirizzo VIHIKARI 10 90440 Kempele Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Manner-Suomi Pohjois- ja Itä-Suomi Pohjois-Pohjanmaa Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 972 500,00 THE UNIVERSITY OF SALFORD Regno Unito Contribution nette de l'UE € 375 000,00 Indirizzo THE CRESCENT 43 M5 4WT Salford Mostra sulla mappa Regione North West (England) Greater Manchester Greater Manchester South West Tipo di attività Higher or Secondary Education Establishments Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 375 000,00 BANGOR UNIVERSITY Regno Unito Contribution nette de l'UE € 148 750,00 Indirizzo COLLEGE ROAD LL57 2DG Bangor Mostra sulla mappa Regione Wales West Wales and The Valleys Gwynedd Tipo di attività Higher or Secondary Education Establishments Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 148 750,00